Today: 10 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

IBM stock price dips into the weekend as investors brace for Jan. 28 earnings

IBM stock price dips into the weekend as investors brace for Jan. 28 earnings

IBM shares fell 0.76% to $292.44 Friday and slipped further after hours ahead of its January 28 earnings report. Investors await fourth-quarter results and guidance, focusing on software and consulting tied to new AI services. IBM Consulting has launched an internal AI delivery platform, but executives warn that scaling real value remains difficult. The company will hold its earnings call Wednesday at 5 p.m. ET.
AstraZeneca stock faces a new test: Iraq terrorism lawsuit revived with NYSE move days away

AstraZeneca stock faces a new test: Iraq terrorism lawsuit revived with NYSE move days away

A U.S. appeals court on Friday revived a lawsuit accusing AstraZeneca and other firms of funding terrorism in Iraq. The ruling was announced after U.S. markets closed; AstraZeneca shares had closed up 1.37% in New York and 0.15% in London. The company plans to switch its U.S. listing from Nasdaq to NYSE on Jan. 30. Investors await Monday’s market reaction.
Morgan Stanley stock slides into weekend as Fed decision, SpaceX IPO talk loom

Morgan Stanley stock slides into weekend as Fed decision, SpaceX IPO talk loom

Morgan Stanley shares fell 2.2% to $179 Friday, underperforming major indexes as bank stocks broadly declined. Goldman Sachs dropped 3.7%, JPMorgan Chase nearly 2%, and Bank of America 1.4%. The S&P 500 was flat, while the Dow lost 0.58%. Investors await the Federal Reserve’s Jan. 28 decision and earnings from Apple, Microsoft, Meta, and Tesla next week.
Novo Nordisk Class B stock heads into Monday with Wegovy pill scripts and Victoza lawsuit in focus

Novo Nordisk Class B stock heads into Monday with Wegovy pill scripts and Victoza lawsuit in focus

Novo Nordisk Class B shares closed up 1.17% at 401.35 crowns in Copenhagen, lifted by strong early U.S. demand for its new Wegovy pill. The company faces a new U.S. lawsuit alleging a “pay-for-delay” scheme for Victoza. Over 18,000 Wegovy pill prescriptions were reported in the U.S. since its Jan. 5 launch. Indian regulators approved local firms to make generic semaglutide ahead of the 2026 patent expiry.
StubHub lawsuit deadline just passed: what’s next in the IPO cash-flow class action

StubHub lawsuit deadline just passed: what’s next in the IPO cash-flow class action

The deadline for investors to seek lead plaintiff status in the StubHub IPO securities class action passed Friday, Hagens Berman said. Plaintiffs allege StubHub’s IPO documents failed to disclose a vendor payment delay that impacted free cash flow. StubHub shares closed at $14.70, down 3.8% and well below the $23.50 IPO price. The court will now review motions and set the next steps in the case.
24 January 2026
GE Aerospace stock slides after earnings selloff — what to watch before Monday

GE Aerospace stock slides after earnings selloff — what to watch before Monday

GE Aerospace shares fell 0.4% to $293.87 Friday, capping a 9.6% slide over five sessions after its fourth-quarter results and 2026 outlook missed analyst profit estimates. Orders jumped 74% to $27 billion, while adjusted revenue rose 20% to $11.9 billion. CEO H. Lawrence Culp Jr. defended pricing and highlighted a $190 billion backlog. Analysts called the drop a valuation reset, not a shift in the engine cycle.
Agricultural Bank of China Class A stock ends lower at 6.75 yuan — what to watch before Monday

Agricultural Bank of China Class A stock ends lower at 6.75 yuan — what to watch before Monday

Agricultural Bank of China’s A-shares closed Friday at 6.75 yuan, down 0.88%, with 395.97 million shares traded. BofA Global Research reported a record $49.2 billion outflow from Chinese equity funds last week. Foreign direct investment in China fell 9.5% in 2025 to 747.7 billion yuan. Investors await China’s PMI data Jan. 31 and the U.S. Fed decision Jan. 28.
Chevron stock price: Venezuela repair plan and Tengiz shutdown put CVX in the spotlight

Chevron stock price: Venezuela repair plan and Tengiz shutdown put CVX in the spotlight

Chevron shares closed up 0.04% at $166.72 after reports said Washington is negotiating with Chevron and oilfield service firms to speed repairs and raise Venezuela’s crude output. Production at Chevron’s Tengiz and Korolev fields in Kazakhstan remains halted after a fire, with repairs expected to finish by January 26. Brent crude rose 2.8% to $65.88 a barrel. Morgan Stanley cut its Chevron price target to $174.
Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

Healthcare stocks brace for a busy week as XLV slips, UnitedHealth earnings and Capitol Hill heat loom

XLV fell 0.51% to $157.48 Friday, trailing the S&P 500, which ended flat. Health insurer CEOs faced House scrutiny over rising premiums and consolidation, with UnitedHealth pledging ACA rebates in 2026. UnitedHealth reports earnings Jan. 27, Regeneron on Jan. 30. Corcept Therapeutics jumped 45% after positive ovarian cancer trial results.
Communication services stocks head into Fed week with Meta under UK probe — what moved XLC

Communication services stocks head into Fed week with Meta under UK probe — what moved XLC

The Communication Services Select Sector SPDR Fund (XLC) closed at $116.96 Friday, up 0.6% after a volatile week. Meta rose 1.72% to $658.76, while Alphabet’s Class C shares slipped 0.73%. UK regulator Ofcom opened an investigation into Meta’s handling of WhatsApp for Business data. Intel shares plunged 17% after a weak forecast, weighing on tech sentiment.
1 210 211 212 213 214 693
Go toTop